The Biotech Growth Trust (BIOG) generated another year of positive absolute and relative performance in 2020. Manager Geoff Hsu of global specialist healthcare investor OrbiMed Capital remains constructive on the outlook for biotech stocks, although he is mindful about the extended bull run in the US stock market. The manager is particularly encouraged by the high levels of biotech industry innovation; he believes that the favourable regulatory environment will continue and does not consider hea ....
09 Mar 2021
The Biotech Growth Trust - Favourable industry fundamentals
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The Biotech Growth Trust - Favourable industry fundamentals
Biotech Growth Trust PLC (BIOG:LON) | 984 0 0.0% | Mkt Cap: 330.9m
- Published:
09 Mar 2021 -
Author:
Mel Jenner -
Pages:
9
The Biotech Growth Trust (BIOG) generated another year of positive absolute and relative performance in 2020. Manager Geoff Hsu of global specialist healthcare investor OrbiMed Capital remains constructive on the outlook for biotech stocks, although he is mindful about the extended bull run in the US stock market. The manager is particularly encouraged by the high levels of biotech industry innovation; he believes that the favourable regulatory environment will continue and does not consider hea ....